Home
James R. Kasinger, General Counsel and Secretary: Crispr Therapeutics CRSP Sell · Filed 03/24
Trade details
- Type
- Insider sale
- Amount
- $148,853.96
- Shares · price
- 3,182 sh · $46.78 a share
- Held after
- 94,308 sh
- Trade date
- 26/03/23
- Filed
- 26/03/24
- Days to filing
- 1 days
Sold 3.3% of holdings
- Share of holding sold
- 3.3%
Crispr Therapeutics trades, last 26 weeks
What else happened in Crispr Therapeutics around then
Filed or reported within 30 days of the trade day · 02/21~04/22James R. Kasinger's recent trades
- James R. Kasinger
Sell10b5-1 planCrispr Therapeutics
Sell10b5-1 planCrispr Therapeutics
CRSP
$626.5K
10,400 sh
$626.5K
Filed 09/24
Traded 09/22
- James R. Kasinger
Planned sale10b5-1 planCrispr Therapeutics
Planned sale10b5-1 planCrispr Therapeutics
CRSP
$626.5K
10,400 sh
$626.5K
Filed 09/22
Traded 09/22
- James R. Kasinger
SellCrispr Therapeutics
SellCrispr Therapeutics
CRSP
$166.5K
3,450 sh
$166.5K
Filed 03/17
Traded 03/16
- James R. Kasinger
SellCrispr Therapeutics
SellCrispr Therapeutics
CRSP
$147.8K
2,800 sh
$147.8K
Filed 03/12
Traded 03/11
- James R. Kasinger
SellCrispr Therapeutics
SellCrispr Therapeutics
CRSP
$111K
2,112 sh
$111K
Filed 02/20
Traded 02/19